BIO President Jim Greenwood: An Interview With PharmAsia News (Part 1 of 2)
This article was originally published in PharmAsia News
Executive Summary
Biotechnology Industry Organization President Jim Greenwood spoke recently with PharmAsia News about developments in Asia, and how BIO is positioning itself in the global marketplace. Greenwood has served as CEO of the trade group since 2005. Prior to joining BIO, he represented Pennsylvania's Eighth District in the U.S. House of Representatives from 1993 to 2005, and served as chairman of the Energy and Commerce Committee Subcommittee on Oversight and Investigation from 2001 to 2004.
You may also be interested in...
Local Thai Drug Makers Urging Compulsory Licensing “Ill-Informed” – PReMA President
PERTH, Australia - Local Thai drug makers are urging the Thai government to issue compulsory licenses for three patented cancer drugs, saying the licenses are legal and would benefit Thailand, the Bangkok Post reported
Local Thai Drug Makers Urging Compulsory Licensing “Ill-Informed” – PReMA President
PERTH, Australia - Local Thai drug makers are urging the Thai government to issue compulsory licenses for three patented cancer drugs, saying the licenses are legal and would benefit Thailand, the Bangkok Post reported
Thailand’s Ministers Of Health, Commerce And Foreign Affairs Conclude Compulsory Licensing Legal
PERTH, Australia - A plan by Thailand's new Public Health Minister Chaiya Sasomsab to review the country's policy on compulsory licensing for four cancer drugs has stalled again after three ministry officials said the policy could not be revoked, the Bangkok Post reported Feb. 20